Notice of the Annual General Meeting of Klaria Pharma Holding AB (publ)
Klaria Pharma Holding AB has scheduled its Annual General Meeting for May 26, 2026, in Stockholm, with proposals to re-elect the current board members and auditor. The Board is seeking authorization to increase share capital by up to 20% to facilitate potential acquisitions or commercial initiatives, subject to shareholder approval.
Key figures
- Board remuneration sek
- 200000
- Total shares outstanding
- 245976152
- Authorization cap percent
- 20
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.